Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

USA ...
Amazon Smile https://smile.amazon.com/ (bookmark)
choose MEBO RESEARCH INC
0.5% to MEBO on your purchases
(no extra cost to you)

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Thursday, June 8, 2017

P&G TMA inhibitor supplement : 1st sign of patent

TRIMETHYLAMINE INHIBITOR THERAPY

The community has been aware since around August 2015 that Procter & Gamble are working on a supplement which will be a trimethylamine inhibitor in the gut.

For the first time, we can see the patent publicly (published on June 1 2017).
Here is the patent via the freepatentsonline website :
PDF version
Via the site (without images) 
P&G Press Release on product (Aug 2015)

The patent is titled :
COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE


It looks like it was filed on Dec 1 2016.

The 'skinny' on this is :
It will be over-the-counter (no prescription needed)
It is being created due to a 2011 paper by Dr Hazen et al at Cleveland Clinic which implicated TMA-oxide as a causal factor in heart disease development.
Dr Hazen et al are working on the supplement under licence to Procter & Gamble.

For now we are digesting the information.
More posts will follow on the subject.
Comments and interpretations are welcome.

Probably the product still has a long way to be on sale.    

The invention provides a method of inhibiting the conversion of choline or carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual a composition comprising a compound set forth in FORMULA (I)

The invention also provides for a method of inhibiting the production of TMA by bacteria comprising administering to the individual a composition comprising a compound set forth in FORMULA (I) wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline or carnitine in the individual.


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

3 comments:

Anonymous said...

This is such a good news for so many people including me ... thanks for sharing and keeping the hope alive ..

Jun 9, 2017, 8:00:00 AM
Anonymous said...

So happy to hear this how long do u think it will be to go on sale

Jun 29, 2017, 5:37:00 PM
Doodledot said...

I am 55 and have suffered with TMAU all my life, this news gives me hope and if the inhibitor really does the job then I will have a whole new lease on life. I cannot wait!

Jan 14, 2018, 11:23:00 AM
Post a Comment